Neurovascular intervention is referred to prevention, diagnosis,
treatment and rehabilitation of vascular disorders of the central
nervous system with minimal invasive procedures or technologies.
Neurovascular disorders are normally treated through micro catheters
or by emolization or recanalization of the abnormal vessels.
One of the major factors contributing to the growth of this market is
the huge patient pool suffering from various neurological disorders.
Other major factors driving the market for neurovascular intervention
devices include advancement in device and treatment technology, high
incidences of ischemic and hemorrhagic strokes, increasing demand for
surgical procedures with minimal invasion, market consolidation and
innovative initiatives taken up by leading market players. However,
major challenge to the growth of this market is high cost involved in
neurovascular intervention treatment.
Geographically, the market is segmented into Asia Pacific, North
America, Europe, and Rest of the World. Presently, North America
holds a lion’s share in the global neurovascular intervention
market, with Europe following its lead. The ever-increasing pool of
geriatrics in these regions and the high rate of obesity have both
contributed to the growth of the market in these regions. On the
other hand, researchers estimate that emerging economies of Japan,
China, and India in Asia Pacific along with countries such as Chile,
Argentina, and Brazil in Latin America will also lend an impetus to
the market due to the improving purchasing power of consumers.
Obtain the Future Market Projections for Neurovascular Intervention at: http://bit.ly/2gj4PFl
Some of the key players operating in the global neurovascular
intervention market are Johnson & Johnson, Cardiatis, S.A.,
Abbott Laboratories, Flexible Stenting Solutions, Inc., Boston
Scientific Corporation, Bayer AG, Chestnut Medical Technologies,
Inc., Covidien PLC, ITGI Medical Ltd., Phenox GmbH, Penumbra, Inc.,
Stryker Corporation, Sequent Medical, Inc., Terumo Corporation, and
NeuroVasx, Inc. The research report provides a granular view of the
competitive landscape present in the global market and estimates the
bargaining power of suppliers and buyers. Additionally, it also
provides an understanding of the threat of new entrants to the
existing players. The researchers have also dedicated a chapter to
explaining the business and marketing strategies likely to be used by
neurovascular intervention market in the coming few years to
strengthen their position in the global market.
Neurovascular intervention market is segmented on following basis:
Disease condition
> Endovascular cerebral aneurysm
> Acute ischemic stroke
> Chronic ischemic stroke
> Intracranial atherosclerotic disease
Device type
> Neurovascular embolic coils
> DNeurovascular liquid embolism
> Intracranial stents & flow diverting devices
> Neurovascular thrombectomy devices
> Carotid stents & embolic protection devices
No comments:
Post a Comment